Jon Glass, MD

Jefferson Health Provider

Jefferson University Physician Jefferson University Physician

Patient Rating

4.6/5 stars

Practice Information

Sidney Kimmel Cancer Center - Washington Township
900 Medical Center Drive
Sewell, NJ 08080-2358
Get Driving Directions
Direct Phone: 856-557-7900
Focus Area:
Neuroscience Services
Medical Oncology
Clinical Focus:

Division Director, Neuro-Oncology
Multidisciplinary Group Lead for CNS tumors, Kimmel Cancer Center

Additional Locations

Voorhees Specialty Care
333 Laurel Oak Road
Voorhees, NJ 08043
Get Driving Directions

Background & Education

Job Title:Professor
Medical School:University Hospital of Brooklyn-SUNY Downstate Medical Center
Internship:Kings County Hospital Center
Residency:Boston Medical Center
Fellowship:Massachusetts General Hospital
Board Certification:Neurology

Professional Appointments & Affiliations

  • Thomas Jefferson University Hospital
  • Methodist Hospital Division of Thomas Jefferson University Hospital



Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0)

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment

Ibrutinib unmasks critical role of bruton tyrosine kinase in primary CNS lymphoma

Current management of primary central nervous system lymphoma

Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era a correlative analysis based on nrg oncology RTOG 0525

Reply to M.C. Chamberlain

Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS lymphoma: NRG oncology RTOG 0227

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better

Primary central nervous system Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly: a clinicopathologic study of five cases

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma

A 60-year-old indian male with altered sensorium and extensive lymphoma of the scalp

A phase i study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas

Improving prognosis of glioblastoma in the 21st century: Who has benefited most?

Characterization and outcomes of optic nerve gliomas: A population-based analysis

Intravascular lymphoma of the CNS

A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies

Hypofractionated stereotactic radiation therapy: An effective therapy for recurrent high-grade gliomas

Central nervous system cancers: Clinical Practice Guidelines in Oncology™

Patient Ratings

Friendliness/courtesy of the care provider :
Explanations the care provider gave you about your problem or condition :
Concern the care provider showed for your questions or worries :
Care provider's efforts to include you in decisions about your care :
Information the care provider gave you about medications (if any) :
Instructions the care provider gave you about follow-up care (if any) :
Degree to which care provider talked with you using words you could understand :
Amount of time the care provider spent with you :
Your confidence in this care provider :
Likelihood of your recommending this care provider to others :
Overall Rating :
Learn more about Patient Ratings